Welcome to our dedicated page for Integer Hldgs news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Hldgs stock.
Integer Holdings Corporation (NYSE: ITGR), a global leader in medical device manufacturing, provides this centralized hub for investors and industry professionals to track its latest developments. Access official press releases, regulatory updates, and strategic announcements from the company powering innovation in cardiac rhythm management, neuromodulation, and vascular medical technologies.
This resource offers critical insights into ITGR's operations as a pure-play medical CDMO, including product launches, manufacturing expansions, and quality certifications. Key updates cover advancements in implantable device components, partnerships with healthcare OEMs, and progress in meeting stringent medical industry standards.
Regularly updated content includes earnings reports, R&D milestones, and supply chain developments relevant to the company's focus on high-reliability medical manufacturing. Visitors can monitor ITGR's strategic positioning in markets served through brands like Greatbatch Medical while staying informed about its transition from diversified holdings to specialized medtech solutions.
Bookmark this page for direct access to verified updates about Integer's manufacturing capabilities, regulatory compliance achievements, and technological innovations that impact global healthcare delivery. Check back frequently to stay informed about developments shaping the future of medical device outsourcing.
Integer Holdings (NYSE:ITGR) reported strong second quarter 2024 results, with sales increasing 9% to $436 million and organic growth of 5%. GAAP net income rose 30% to $31 million, while non-GAAP adjusted net income increased 17% to $45 million. The company's GAAP diluted EPS grew to $0.88 per share, and non-GAAP adjusted EPS reached $1.30 per share.
Integer's president and CEO, Joseph Dziedzic, highlighted the company's successful strategy execution, with expectations of 9% to 11% above-market sales growth for 2024. The company has raised its full-year adjusted operating income growth outlook to 14% to 21%. Notable product line performances include an 11% increase in Cardio & Vascular sales and a 9% rise in Cardiac Rhythm Management & Neuromodulation sales.
Integer Holdings (NYSE: ITGR) has announced that its 2.125% Convertible Senior Notes due 2028 are now convertible from July 1, 2024, to September 30, 2024. The notes can be converted into cash, shares of Integer's common stock, or a combination of both, at a conversion rate of 11.4681 shares per $1,000 principal amount, equivalent to $87.20 per share.
Additionally, Integer has amended its credit agreement, increasing its revolving credit facility by $300 million, bringing the total to $800 million. This move aims to enhance the company's liquidity, supporting its long-term strategic objectives while maintaining a debt leverage target of 2.5 to 3.5.
Integer Holdings (NYSE: ITGR) announced it will release its financial and operational results for the second quarter of 2024 on July 25, 2024, at 7 a.m. CT (8 a.m. ET). A webcast will follow at 8 a.m. CT (9 a.m. ET) where company management will discuss the results. Investors and interested parties can access the webcast through the company's investor relations website.
Integer Holdings (NYSE: ITGR), a leading global medical device contract development and manufacturing organization, announced its participation in the 2024 Truist Securities MedTech Conference.
The event will take place in Boston on June 17-18, 2024. Integer's President and CEO, Joseph Dziedzic, will present during a fireside chat scheduled for June 18 at 1:55 p.m. ET.
A live webcast of the presentation will be available on the Investor Relations section of the company’s website.
Integer Holdings will showcase its strategic investments at Heart Rhythm 2024, focusing on comprehensive end-to-end solutions to support customers' growth and innovation. The company's recent acquisition of Pulse Technologies brings advanced surface texturing and coating technologies, enhancing the performance and reliability of medical devices across various applications.
Integer Holdings (NYSE: ITGR) will present at the 2024 Bank of America Securities Healthcare Conference on May 14. CEO Joseph Dziedzic will speak at 10:40 a.m. PDT. The live webcast can be accessed on the Investor Relations section of the Integer website.
FAQ
What is the current stock price of Integer Hldgs (ITGR)?
What is the market cap of Integer Hldgs (ITGR)?
